title: Highlights of the North American Cystic Fibrosis Conference 2009.
authors.affiliation: Manchester Adult Cystic Fibrosis Centre, University Hospital South Manchester NHS Foundation Trust, Southmoor Road, Manchester M23 9LT, UK. andrew.jones@uhsm.nhs.uk
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Jones
authors.forename: Jennifer
authors.initials: J
authors.lastname: Helm
authors.forename: Ruth
authors.initials: R
authors.lastname: Richmond
authors.forename: Emily
authors.initials: E
authors.lastname: Mason-Smith
authors.forename: Amanda
authors.initials: A
authors.lastname: Brennan
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000401:mortality / Q000628:therapy*; D003920:Diabetes Mellitus / Q000175:diagnosis; D006801:Humans; D017053:Infection Control; D009656:North America; D011552:Pseudomonas Infections / Q000188:drug therapy; D011785:Quality Assurance, Health Care; D016019:Survival Analysis; D014807:Vitamin D / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D014815:Vitamins; D014807:Vitamin D; D017963:Azithromycin